These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7900383)

  • 21. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J; Dzúrik R
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension in the elderly: 24 h ambulatory blood pressure results from a placebo-controlled trial.
    Neutel JM; Smith DH; Lefkowitz MP; Cargo P; Alemayehu D; Weber MA
    J Hum Hypertens; 1995 Sep; 9(9):723-7. PubMed ID: 8551485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
    Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
    Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A clinical study of the verapamil and captopril combination in hypertensive patients uncontrolled by monotherapy. An evaluation by recording the 24-hour ambulatory blood pressure].
    Mora-Macià J; Ocón Pujadas J; Fernández Vidal P; Garrido García J; Velasco Quintana J; del Río Pérez G
    Med Clin (Barc); 1993 Apr; 100(14):526-30. PubMed ID: 8469038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of a sustained-release formulation for antihypertensive therapy.
    Skaer TL; Sclar DA; Markowski DJ; Won JK
    J Hum Hypertens; 1993 Oct; 7(5):519-22. PubMed ID: 8263896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Verapamil-associated liver injury].
    Odeh M; Oliven A
    Harefuah; 1998 Jan; 134(1):36-7. PubMed ID: 9517278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease.
    White WB; Johnson MF; Anders RJ; Elliott WJ; Black HR
    Am Heart J; 2001 Dec; 142(6):1010-5. PubMed ID: 11717605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertension therapy--an update.
    Cubberley RB
    J Natl Med Assoc; 1987 Nov; 79(11):1161-3. PubMed ID: 3694695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Covera-HS offers proven protection in hypertension and angina in alignment with circadian rhythm.
    Adv Nurse Pract; 1997 Aug; 5(8):66. PubMed ID: 9459960
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of COER-verapamil on circadian pattern of forearm vascular resistance and blood pressure.
    Nguyen BN; Parker RB; Noujedehi M; Sullivan JM; Johnson JA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1480-7. PubMed ID: 11185670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
    Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
    Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of verapamil on reinfarction and cardiovascular events in patients with arterial hypertension included in the Danish Verapamil Infarction Trial II. The Danish Study Group on Verapamil in Myocardial Infarction.
    Jespersen CM; Hansen JF
    J Hum Hypertens; 1994 Feb; 8(2):85-8. PubMed ID: 8207744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The possibilities of isoptin treatment of pulmonary hypertension in patients with chronic obstructive bronchitis].
    Kakhnovskiĭ IM; Sivkov SI; Markova ZS; Ivanova IL; Sivkov AS
    Klin Med (Mosk); 1997; 75(12):48-52. PubMed ID: 9503814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verapamil in hypertension--a long term study.
    Zawar PB; Chawhan RN; Gosavi SV; Gokhale PD; Jadhav AB
    Indian Heart J; 1982; 34(1):38-41. PubMed ID: 7084985
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
    Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
    Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the efficacy and tolerance of the new delayed-action angiotensin-converting enzyme inhibitor cilazapril in patients with hypertension (preliminary report)].
    Vil'chinskaia MIu; Sorokin EV; Podinovskaia IaV; Karpov IuA
    Ter Arkh; 1993; 65(9):32-4. PubMed ID: 8303591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of verapamil in intermittent claudication.
    Switzer DS
    J Fam Pract; 1997 Apr; 44(4):337. PubMed ID: 9108822
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of verapamil in essential hypertension].
    Sokolov AM; Ivanova GA; Suloeva MN
    Vrach Delo; 1986 Jul; (7):43-6. PubMed ID: 3750995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.